Literature DB >> 15616334

Characterization of In100, a new integron carrying a metallo-{beta}-lactamase and a carbenicillinase, from Pseudomonas aeruginosa.

Sandra Quinteira1, João Carlos Sousa, Luísa Peixe.   

Abstract

In100, a new integron carrying a carbapenemase gene (bla(VIM-2)) associated with a carbenicillinase (blaP1b) and aminoglycoside resistance genes (aacA4 and aadA2), was detected in a Pseudomonas aeruginosa clinical isolate. The particular gene cassette organization of In100 seems to reflect the evolution of antibiotic usage in therapeutics.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15616334      PMCID： PMC538865          DOI： 10.1128/AAC.49.1.451-453.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Efficiency of recombination reactions catalyzed by class 1 integron integrase IntI1.

Authors:  C M Collis; G D Recchia; M J Kim; H W Stokes; R M Hall
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.

Authors:  L Poirel; T Lambert; S Türkoglü; E Ronco; J Gaillard; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates.

Authors:  H Pai; J Kim; J Kim; J H Lee; K W Choe; N Gotoh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Mechanisms of resistance to the carbapenems.

Authors:  D Livingstone; M J Gill; R Wise
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

5.  Revised analysis of aadA2 gene of plasmid pSa.

Authors:  A Bito; M Susani
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

6.  PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams.

Authors:  K Senda; Y Arakawa; S Ichiyama; K Nakashima; H Ito; S Ohsuka; K Shimokata; N Kato; M Ohta
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  Expression of antibiotic resistance genes in the integrated cassettes of integrons.

Authors:  C M Collis; R M Hall
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 9.  Forty years of beta-lactam research.

Authors:  G N Rolinson
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790

10.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191
View more
  9 in total

1.  First isolation of blaVIM-2 in an environmental isolate of Pseudomonas pseudoalcaligenes.

Authors:  Sandra Quinteira; Helena Ferreira; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

2.  Multiniche screening reveals the clinically relevant metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa far from the hospital setting: an ongoing dispersion process?

Authors:  Sandra Quinteira; Luísa Peixe
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

3.  In99, an In100-related integron, its occurrence and prevalence in clinical Pseudomonas aeruginosa strains from a central region of Portugal.

Authors:  T Caetano; S Ferreira; A P Mondego; A Correia; S Mendo
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

4.  Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis.

Authors:  Rodrigo E Mendes; Katia A Kiyota; Jussimara Monteiro; Mariana Castanheira; Soraya S Andrade; Ana C Gales; Antonio C C Pignatari; Sergio Tufik
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

5.  Characterization of the pJB12 Plasmid from Pseudomonas aeruginosa Reveals Tn6352, a Novel Putative Transposon Associated with Mobilization of the blaVIM-2-Harboring In58 Integron.

Authors:  João Botelho; Filipa Grosso; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

6.  Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates.

Authors:  Johann D D Pitout; Barbara L Chow; Daniel B Gregson; Kevin B Laupland; Sameer Elsayed; Deirdre L Church
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

7.  Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands.

Authors:  P D Croughs; B Li; J A A Hoogkamp-Korstanje; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-08       Impact factor: 3.267

8.  Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene.

Authors:  Victoria I Siarkou; Danai Vitti; Efthimia Protonotariou; Alexandros Ikonomidis; Danai Sofianou
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

9.  Microbial diversity and activity in the Nematostella vectensis holobiont: insights from 16S rRNA gene sequencing, isolate genomes, and a pilot-scale survey of gene expression.

Authors:  Jia Y Har; Tim Helbig; Ju H Lim; Samodha C Fernando; Adam M Reitzel; Kevin Penn; Janelle R Thompson
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.